HBSP (USA)
-
Reinventing Brainlab
Herzlinger, Regina E.; Dessain, Vincent; Misztal, KarolCase HBS-313069-EStrategyThe management of Germany's Brainlab AG, a leading provider of software-driven oncology and surgery solutions, needs to evaluate strategic options for proceeding without an exclusive hardware partner in its most profitable business segment.Starting at €8.20
-
The Tavistock Group and the Australian Agricultural Company
Roscini, Dante; Preble, MatthewCase HBS-717009-EEconomicsIn late 2015, Dr. Shehan Dissanayake, a managing director and board member of the Bahamian-based investment firm The Tavistock Group (Tavistock), the largest single shareholder in the Australian Agricultural Company (AACo), one of the country's largest agribusinesses, faces a potentially challenging future operating environment in Australia. The country's national government has recently instituted changes to its agricultural foreign direct inves...Starting at €8.20
-
Reinventing Brainlab (B)
Herzlinger, Regina E.; Misztal, KarolCase HBS-314054-EStrategyThe management of Germany's Brainlab AG, a leading provider of software-driven oncology and surgery solutions, needs to evaluate strategic options for proceeding without an exclusive hardware partner in its most profitable business segment.Starting at €5.74
-
The "Wonder Drug" that Killed Babies
Krieger, Joshua Lev; Nicholas, Tom; Preble, MatthewCase HBS-818044-EEconomicsIn the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children may have been affected. Just a handful of these children were born in the U.S., where safety concerns were raised by Dr. Frances Oldham Kelsey, the medical officer handling the thali...Starting at €8.20